- Current report filing (8-K)
21 November 2008 - 12:30AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
8-K
CURRENT
REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE
SECURITIES EXCHANGE ACT OF 1934
Date
of report (date of earliest event reported): November 20, 2008
Cougar
Biotechnology, Inc.
(Exact
name of registrant as specified in its charter)
Delaware
(State
or other jurisdiction of incorporation)
001-33871
|
|
20-2903204
|
(Commission File Number)
|
|
(IRS Employer Identification No.)
|
10990
Wilshire Blvd, Suite 1200
Los
Angeles, CA 90024
|
(Address of principal executive offices) (Zip Code)
|
(310) 943-8040
(Registrant’s telephone number, including area
code)
N/A
(Former name or former address, if changed
since last report)
Check the
appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any
of the following provisions:
⃞
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
⃞
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
⃞
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
⃞
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Item 8.01 Other Events.
On November 20, 2008, Cougar Biotechnology, Inc. (the “Company”) issued
a press release announcing the initiation of a Phase I/II clinical trial
of its product candidate CB7630 in patients with advanced breast cancer.
A copy of the press release is attached hereto as Exhibit 99.1 and
incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit No.
|
|
Description
|
99.1
|
|
Press release dated November 20, 2008.
|
SIGNATURE
Pursuant to
the requirements of the Securities Exchange Act of 1934, the registrant
has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
|
|
COUGAR BIOTECHNOLOGY, INC.
|
|
|
|
|
|
|
|
|
Date:
|
November 20, 2008
|
|
By:
|
/s/ Charles R. Eyler
|
|
|
|
Charles R. Eyler
|
|
|
|
Sr. Vice President, Finance
|
INDEX TO EXHIBITS FILED WITH THIS REPORT
Exhibit No.
|
|
Description
|
99.1
|
|
Press release dated November 20, 2008
|
Cougar Biotechnology (MM) (NASDAQ:CGRB)
Historical Stock Chart
From Jun 2024 to Jul 2024
Cougar Biotechnology (MM) (NASDAQ:CGRB)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Cougar Biotechnology (MM) (NASDAQ): 0 recent articles
More News Articles